Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biofrontera Inc. - Common Stock
(NQ:
BFRI
)
0.6391
+0.0691 (+12.12%)
Streaming Delayed Price
Updated: 11:49 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biofrontera Inc. - Common Stock
< Previous
1
2
3
Next >
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025
May 06, 2025
Via
ACCESS Newswire
Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
December 03, 2024
Via
ACCESSWIRE
Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024
November 01, 2024
Via
ACCESSWIRE
Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference
September 25, 2024
Via
ACCESSWIRE
Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024
August 09, 2024
Via
ACCESSWIRE
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
May 15, 2024
Via
ACCESSWIRE
CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
March 15, 2024
Via
ACCESSWIRE
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
March 15, 2024
Via
ACCESSWIRE
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
May 06, 2024
Via
ACCESSWIRE
Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
May 03, 2024
Via
ACCESSWIRE
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
March 26, 2024
Via
ACCESSWIRE
Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024
March 08, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Closes on Private Placement Valued at Up to $16M
March 04, 2024
Via
Investor Brand Network
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 09, 2023
Via
ACCESSWIRE
Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)
October 10, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
February 23, 2024
Via
ACCESSWIRE
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
February 20, 2024
Via
ACCESSWIRE
Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules
February 20, 2024
Via
ACCESSWIRE
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use
February 05, 2024
Via
ACCESSWIRE
Biofrontera Inc. Announces Preliminary Third Quarter Revenues
October 04, 2023
Via
ACCESSWIRE
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update
August 11, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Last Patient Enrolled in Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Basal Cell Carcinoma
August 10, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
January 11, 2024
Via
ACCESSWIRE
BioMedNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Announces $4.5M Registered Direct
November 21, 2023
Via
Investor Brand Network
Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10
November 03, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules
October 31, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference
October 05, 2023
Via
ACCESSWIRE
Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts
August 29, 2023
Via
ACCESSWIRE
Biofrontera Inc. Announces Positive Results from Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz(R)
August 28, 2023
Via
ACCESSWIRE
Biofrontera Inc. to Report Second Quarter Financial Results on August 11, 2023
August 04, 2023
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
